Goethe University
Clinical trials sponsored by Goethe University, explained in plain language.
-
Immunotherapy duo shows promise for Tough-to-Treat kidney cancer
Disease control CompletedThis phase 2 trial tested whether combining two immunotherapy drugs, nivolumab and ipilimumab, works better than standard treatments for people with advanced non-clear cell kidney cancer. About 316 participants received either the drug combo or standard therapy. The main goal was…
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 23, 2026 11:56 UTC
-
Tailored combo therapy boosts leukemia fight in adults
Disease control CompletedThis study tested a personalized, intensive treatment plan for adults aged 18-55 with newly diagnosed acute lymphoblastic leukemia (ALL) or lymphoblastic lymphoma. The approach used strong chemotherapy, targeted drugs like nelarabine for T-cell ALL, and risk-based stem cell trans…
Phase: PHASE3 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 22, 2026 12:09 UTC
-
New combo therapy offers hope for older leukemia patients
Disease control CompletedThis study tested a new treatment approach for adults over 55 with a specific type of leukemia (B-precursor ALL). The goal was to see if using a targeted drug called blinatumomab along with a reduced dose of chemotherapy could help patients achieve remission with fewer side effec…
Phase: PHASE2 • Sponsor: Goethe University • Aim: Disease control
Last updated Jun 12, 2026 12:08 UTC